Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2021-06-11 Annual Report
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company MedPacto, which is the Korean equivalent of an Annual Report (10-K). It contains detailed financial statements, management discussion and analysis, governance information, and auditor reports for the fiscal year 2020. Although the document includes a 'Correction Report' (정정신고) header, the content provided is the full annual report itself, not just an announcement of the report. FY 2020
2021-06-11 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, specifically the resignation of an outside director. This falls under the category of Board/Management Information (MANG).
2021-06-03 Korean
투자판단관련주요경영사항(진행성 데스모이드 종양(공격성 섬유종증)에서 이매티닙 단독요법 대비 백토서팁 및 이매티닙 병용요법 비교시험 (MP-VAC-206) 계획 식품의약품안전처(MFDS) IND 신청)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from a Korean company (MedPacto) regarding the filing of an Investigational New Drug (IND) application with the Ministry of Food and Drug Safety (MFDS) for a clinical trial. This type of disclosure, which reports a specific material event (clinical trial application) to the regulatory exchange, falls under the category of general regulatory announcements for material corporate developments.
2021-05-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (purchases and sales) by an executive (Kim Seon Jeong) of MedPacto. This type of filing is a standard regulatory disclosure for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2021-05-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, location, purpose, and instructions on where to download the actual presentation materials later. Per the 'Menu vs Meal' rule, since this is an announcement of an event and not the presentation itself, it is classified as a Report Publication Announcement (RPA).
2021-05-20 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for MedPacto, Inc. covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.